These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29089195)

  • 21. Vigorous hepatitis C virus-specific CD4+ and CD8+ T cell responses induced by protein immunization in the presence of Montanide ISA720 plus synthetic oligodeoxynucleotides containing immunostimulatory cytosine-guanine dinucleotide motifs.
    Sugauchi F; Wang RY; Qiu Q; Jin B; Alter HJ; Shih JW
    J Infect Dis; 2006 Feb; 193(4):563-72. PubMed ID: 16425136
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunization With a Subunit Hepatitis C Virus Vaccine Elicits Pan-Genotypic Neutralizing Antibodies and Intrahepatic T-Cell Responses in Nonhuman Primates.
    Li D; Wang X; von Schaewen M; Tao W; Zhang Y; Heller B; Hrebikova G; Deng Q; Sun Q; Ploss A; Zhong J; Huang Z
    J Infect Dis; 2017 Jun; 215(12):1824-1831. PubMed ID: 28398489
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Safety and immunogenicity of HCV E1E2 vaccine adjuvanted with MF59 administered to healthy adults.
    Frey SE; Houghton M; Coates S; Abrignani S; Chien D; Rosa D; Pileri P; Ray R; Di Bisceglie AM; Rinella P; Hill H; Wolff MC; Schultze V; Han JH; Scharschmidt B; Belshe RB
    Vaccine; 2010 Aug; 28(38):6367-73. PubMed ID: 20619382
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The bovine viral diarrhea virus E2 protein formulated with a novel adjuvant induces strong, balanced immune responses and provides protection from viral challenge in cattle.
    Snider M; Garg R; Brownlie R; van den Hurk JV; van Drunen Littel-van den Hurk S
    Vaccine; 2014 Nov; 32(50):6758-64. PubMed ID: 25454860
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunization with hepatitis C virus-like particles induces humoral and cellular immune responses in nonhuman primates.
    Jeong SH; Qiao M; Nascimbeni M; Hu Z; Rehermann B; Murthy K; Liang TJ
    J Virol; 2004 Jul; 78(13):6995-7003. PubMed ID: 15194776
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Mice Antibody Response to Conserved Nonadjuvanted Multiple Antigenic Peptides Derived from E1/E2 Regions of Hepatitis C Virus.
    Abdelhafez TH; Bader El Din NG; Tabll AA; Mashaly MM; Dawood RM; Yassin NA; El-Awady MK
    Viral Immunol; 2017 Jun; 30(5):359-365. PubMed ID: 28402196
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Intranasal c-di-GMP-adjuvanted plant-derived H5 influenza vaccine induces multifunctional Th1 CD4+ cells and strong mucosal and systemic antibody responses in mice.
    Madhun AS; Haaheim LR; Nøstbakken JK; Ebensen T; Chichester J; Yusibov V; Guzman CA; Cox RJ
    Vaccine; 2011 Jul; 29(31):4973-82. PubMed ID: 21600260
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clearance of genotype 1b hepatitis C virus in chimpanzees in the presence of vaccine-induced E1-neutralizing antibodies.
    Verstrepen BE; Depla E; Rollier CS; Mares G; Drexhage JA; Priem S; Verschoor EJ; Koopman G; Granier C; Dreux M; Cosset FL; Maertens G; Heeney JL
    J Infect Dis; 2011 Sep; 204(6):837-44. PubMed ID: 21849281
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Broadening CD4
    Filskov J; Mikkelsen M; Hansen PR; Christensen JP; Thomsen AR; Andersen P; Bukh J; Agger EM
    J Virol; 2017 Jul; 91(14):. PubMed ID: 28446674
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cooperative effects of immune enhancer TPPPS and different adjuvants on antibody responses induced by recombinant ALV-J gp85 subunit vaccines in SPF chickens.
    Li Y; Meng F; Cui S; Fu J; Wang Y; Cui Z; Chang S; Zhao P
    Vaccine; 2017 Mar; 35(12):1594-1598. PubMed ID: 28237498
    [TBL] [Abstract][Full Text] [Related]  

  • 31. [Two HCV vaccines based on adeno-associated virus vectors elicited durable and effective immune responses in mice].
    Deng Y; Zhang K; Chen H; Liu HM; Wu XB; Ruan L; Tan WJ
    Bing Du Xue Bao; 2009 Jul; 25(4):261-6. PubMed ID: 19769158
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Structure-Based Design of Hepatitis C Virus Vaccines That Elicit Neutralizing Antibody Responses to a Conserved Epitope.
    Pierce BG; Boucher EN; Piepenbrink KH; Ejemel M; Rapp CA; Thomas WD; Sundberg EJ; Weng Z; Wang Y
    J Virol; 2017 Oct; 91(20):. PubMed ID: 28794021
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hepatitis C virus soluble E2 in combination with QuilA and CpG ODN induces neutralizing antibodies in mice.
    Naarding MA; Falkowska E; Xiao H; Dragic T
    Vaccine; 2011 Apr; 29(16):2910-7. PubMed ID: 21338680
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Recombinant glycoprotein B vaccine formulation with Toll-like receptor 9 agonist and immune-stimulating complex induces specific immunity against multiple strains of cytomegalovirus.
    Dasari V; Smith C; Zhong J; Scott G; Rawlinson W; Khanna R
    J Gen Virol; 2011 May; 92(Pt 5):1021-1031. PubMed ID: 21307228
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Antibodies Targeting Novel Neutralizing Epitopes of Hepatitis C Virus Glycoprotein Preclude Genotype 2 Virus Infection.
    Deng K; Liu R; Rao H; Jiang D; Wang J; Xie X; Wei L
    PLoS One; 2015; 10(9):e0138756. PubMed ID: 26406225
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Oral immunization with attenuated Salmonella carrying a co-expression plasmid encoding the core and E2 proteins of hepatitis C virus capable of inducing cellular immune responses and neutralizing antibodies in mice.
    Cao J; Chen Z; Ren Y; Luo Y; Cao M; Lu W; Zhao P; Qi Z
    Vaccine; 2011 May; 29(20):3714-23. PubMed ID: 21396407
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Evaluation of the immunogenicity of liposome encapsulated HVR1 and NS3 regions of genotype 3 HCV, either singly or in combination.
    Gupte GM; Arankalle VA
    Virol J; 2012 Mar; 9():74. PubMed ID: 22452828
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Differential Immune Responses in Mice Immunized with Recombinant Neutralizing Epitope Protein of Hepatitis E Virus Formulated with Liposome and Alum Adjuvants.
    Joshi SS; Arankalle VA
    Viral Immunol; 2016; 29(6):350-60. PubMed ID: 27285290
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Protective T Cell and Antibody Immune Responses against Hepatitis C Virus Achieved Using a Biopolyester-Bead-Based Vaccine Delivery System.
    Martínez-Donato G; Piniella B; Aguilar D; Olivera S; Pérez A; Castañedo Y; Alvarez-Lajonchere L; Dueñas-Carrera S; Lee JW; Burr N; Gonzalez-Miro M; Rehm BH
    Clin Vaccine Immunol; 2016 Apr; 23(4):370-8. PubMed ID: 26888185
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bis-(3',5')-cyclic dimeric adenosine monophosphate: strong Th1/Th2/Th17 promoting mucosal adjuvant.
    Ebensen T; Libanova R; Schulze K; Yevsa T; Morr M; Guzmán CA
    Vaccine; 2011 Jul; 29(32):5210-20. PubMed ID: 21619907
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.